This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Sqz Biotechnologies Company. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Anita Venkitaraman: Innovator in Cancer Immunotherapy
Introduction
Anita Venkitaraman is an accomplished inventor based in Watertown, MA (US). She is currently associated with Stemcell Technologies Canada Inc. Despite having no granted patents to her name, her work focuses on innovative methods to stimulate immune responses in cancer treatment.
Latest Patent Applications
Anita has filed several patent applications that showcase her research in cancer immunotherapy. One of her latest applications is titled "Methods to Stimulate Immune Responses to Mutant Ras Using Anucleate Cells." This application provides details on anucleate cells that comprise a mutated Ras antigen, such as a mutated K-Ras antigen. It outlines methods for manufacturing these anucleate cells and their use in stimulating immune responses, treating, and vaccinating individuals with cancers associated with Ras mutations.
Another significant application is "Methods to Stimulate Immune Responses to Mutant Ras Using Nucleated Cells." This application discusses nucleated cells that also contain a mutated Ras antigen. It details methods for manufacturing these nucleated cells and their application in stimulating immune responses, treating, and vaccinating individuals with cancer linked to Ras mutations.
Conclusion
Anita Venkitaraman is making strides in the field of cancer immunotherapy through her innovative research and patent applications. Her work has the potential to contribute significantly to the treatment of cancers associated with Ras mutations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile